Anti-Human KIRD2 Subgroup Recombinant Antibody

Name: Anti-Human KIRD2 Subgroup Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1284

YR1284

科研级 Lirilumab ( 利瑞鲁单抗 ), Anti-KIRD2 Subgroup Recombinant Antibody, Research Grade Lirilumab

DATASHEET MSDS

Product Description

Alias	科研级 Lirilumab ( 利瑞鲁单抗 ), Anti-KIRD2 Subgroup Recombinant Antibody, Research Grade Lirilumab
Catalog Number	YR1284
Molecular Name	Lirilumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	Human IgG1
Formulation	PBS, pH7.5
Background	Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3. This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb.
CAS Number	1000676-41-4
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	KIRD2 Subgroup[Homo sapiens]

Login